BIT 2.63% 3.9¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-32

  1. 2,846 Posts.
    lightbulb Created with Sketch. 285
    This study was a particularly complex and time-consuming trial. The results reported here are preliminary, and ongoing analysis of this BIT225-011 trial and the BIT225-010 HIV-1 trial in a treatment-naïve population will be reported when complete.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.001(2.63%)
Mkt cap ! $35.18M
Open High Low Value Volume
3.9¢ 4.1¢ 3.8¢ $65.43K 1.670M

Buyers (Bids)

No. Vol. Price($)
1 46055 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 59151 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.